SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is surging as investors react positively to reports of a new cloud-computing initiative designed to monetize the company's excess AI compute capacity. While community sentiment is divided, with some expressing skepticism regarding Meta's strategic pivot and capital efficiency, others view this as a potential revenue-generating shift that could improve long-term margins and ROI.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant volatility and trading momentum as investors pivot their focus toward the company's expanding oncology pipeline and the upcoming FDA advisory committee vote on its mRNA-based influenza vaccine. Community sentiment remains deeply divided, with bulls highlighting the platform's long-term diversification strategy while bears focus on regulatory hurdles, high short interest, and ongoing debates regarding mRNA technology.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending due to intense retail interest surrounding its potential as a short squeeze candidate, driven by a combination of high short interest and a exceptionally low public float. The community is actively debating the stock's turnaround prospects and comparing it to other fast-food retail plays, while some investors are closely monitoring recent debt refinancing news as a key catalyst for volatility.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is facing intense volatility as investors react to reports of Meta Platforms potentially launching a cloud business to monetize its own excess AI compute capacity. While many in the community view the sell-off as a knee-jerk reaction to narrative-driven headlines, others are debating whether this signals a long-term shift in the competitive landscape for AI infrastructure providers.

General Mills, Inc. engages in the manufacture of food. Its portfolio of brands includes household names like Cheerios, Nature Valley, Blue Buffalo, Häagen-Dazs, Old El Paso, Pillsbury, Betty Crocker, Totino’s, Annie’s, Wanchai Ferry and more. It operates through the following segments: North America Retail, International, North America Pet, and North America Foodservice. The North America Retail segment includes grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, convenience stores, and e-commerce grocery providers. The International segment refers to the retail and foodservice businesses outside of the US and Canada. The North America Pet segment includes pet food products sold in national pet superstore chains, e-commerce retailers, grocery stores, regional pet store chains, mass merchandisers, and veterinary clinics and hospitals. The North America Foodservice segment offers ready-to-eat cereals, snacks, refrigerated yogurt, frozen meals, unbaked and fully baked frozen dough products, baking mixes, and bakery flour. The company was founded by Cadwallader C. Washburn on June 20, 1928 and is headquartered in Minneapolis, MN.

General Mills, Inc.

General Mills is trending after slashing its fiscal 2026 outlook due to persistent consumer demand challenges, margin pressures, and the impact of input inflation. This significant guidance cut has triggered a sector-wide selloff, leading to intense community debate regarding the company's long-term turnaround strategy and the reliability of its dividend amidst ongoing volatility.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is generating intense debate among retail investors, fueled by a high short interest and anticipation that the stock is positioned for a significant short squeeze. The community is actively discussing the company's expansion into enterprise voice AI, while debating whether current technical patterns signal a bottom or continued downside volatility.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is trending as investors debate whether the sector's parabolic rise represents a sustainable AI-driven supercycle or a crowded, late-stage speculative bubble. While bulls point to robust capital expenditures and memory-led demand as structural foundations, bears warn of extreme valuation levels and potential downside risks from sector-wide profit-taking.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending downward following reports that Meta plans to monetize its excess AI compute capacity, sparking investor concerns over potential long-term competition and supply-side pressures for independent GPU cloud providers. While the community is debating whether this news represents a genuine structural shift or a temporary market overreaction to headline-driven fear, active discussions are centered on the durability of existing hyperscaler contracts and the technical significance of current support levels.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is facing significant volatility driven by heavy concentration in South Korean memory giants and ongoing concerns regarding regional market instability and antitrust scrutiny. While investors remain focused on the long-term structural tailwinds of the memory supercycle and upcoming listing events, the stock is experiencing intense selling pressure as traders grapple with profit-taking and sentiment shifts in the broader semiconductor sector.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending due to reports that its advanced manufacturing capacity remains structurally constrained despite aggressive capital expenditure, fueling sustained AI-driven demand and institutional focus on its pricing power. The community is actively debating the company's long-term dominance in the semiconductor supply chain and assessing how its critical role in advanced node fabrication and packaging influences global AI investment cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KYMR Stock Soars 51% YTD on Progress of Atopic Dermatitis Drug

KYMR surges 51% year to date as KT-621 advances in atopic dermatitis and asthma, with pivotal data timelines accelerating and pipeline momentum building.

SNY's Nexviazyme Meets Goals in Infantile-Onset Pompe Disease Study

Sanofi's phase III Baby-COMET study meets all goals for Nexviazyme in infantile-onset Pompe disease, paving the way for a planned U.S. filing in H2 2026.

Sanofi Reports Data From Nexviazyme Study, Says It Meets All Endpoints

Sanofi says Nexviazyme met all Phase 3 trial endpoints in infantile Pompe disease, supporting a planned US label expansion filing in 2026.read more...

What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?

ABBV surged nearly 11% in a week as acquisitions, new approvals and pipeline expansion strengthen confidence in its long-term growth strategy.

EU Launches Antitrust Probe Into Sanofi Over Allegedly Misleading Flu Vaccine Claims (UPDATED)

EU opens antitrust probe into Sanofi over claims it disparaged rival flu vaccine Fluad in Germany and France.read more...

Deutsche Bank Cuts PT on Sanofi (SNY) - Here's Why

Deutsche Bank Cuts PT on Sanofi (SNY) - Here's Why...

Nurix Stock Up 29% in a Month: Here's What You Should Know

NRIX rallies on its collaboration with Roche for bexobrutideg, featuring a $700 million upfront payment and potential milestone payouts of up to $2.3 billion.

Regeneron's Applications for gMG Drug Accepted by FDA and EMA 

Regeneron's cemdisiran won FDA Priority Review and EMA filing acceptance for gMG, backed by phase III data and a potentially unique dosing schedule.

Merck's Anti-TL1A Antibody Meets Goal in Ulcerative Colitis Study

MRK's tulisokibart meets goals in a late-stage ulcerative colitis study, strengthening a key pipeline asset as the company looks beyond Keytruda.

EU Clears SNY's Cenrifki for Secondary Progressive Multiple Sclerosis

Sanofi wins EU nod for Cenrifki in secondary progressive multiple sclerosis without relapses, while Wayrilz gets Japan nod for immune thrombocytopenia.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

DNTH Stock Clocks Best Day In Over 3 Months On Strong Nerve Disorder Study Results

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.10	--	--	N/A
Q1 '26	$1.04	$1.10	6.21%	BEAT
Q4 '25	$0.84	$0.91	8.38%	BEAT
Q3 '25	$1.58	$1.69	7.23%	BEAT
Q2 '25	$0.96	$0.91	-5.11%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

SNYSanofi-Aventis

Upcoming Earnings: Q2 '26

Historical Earnings

Latest SNY News